Review



pbpk model using simcyp® v21 simulator  (Simcyp)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Simcyp pbpk model using simcyp® v21 simulator
    Pbpk Model Using Simcyp® V21 Simulator, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/13+compartment+full+pbpk+model+simcyp++population+based+simulator+version+12+1/pm39218776-551-31-31
    Average 90 stars, based on 1 article reviews
    pbpk model using simcyp® v21 simulator - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Clinical Proteomics:

    Article Title: Precision Medicine in Oncology: Imatinib Dosing in the Obese Cancer Population Using Virtual Clinical Trials.
    Article Snippet: .. The simulations of imatinib plasma profiles on adult cancer populations were performed using the PBPK modeling platform Simcyp Version 21 (Simcyp Ltd., a Certara company, Sheffield, UK). ..

    other:

    Article Title: Determination of Vatiquinone Drug‐Drug Interactions, as CYP450 Perpetrator and Victim, Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation
    Article Snippet: A PBPK model (Simcyp Simulator version 21, full model) was developed using parameters obtained from in vitro studies, in silico estimation and optimization, and two clinical studies.

    Article Title: Determination of Vatiquinone Drug-Drug Interactions, as CYP450 Perpetrator and Victim, Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation.
    Article Snippet: A PBPK model (Simcyp Simulator version 21, full model) was developed using parameters obtained from in vitro studies, in silico estimation and optimization,and two clinical studies.A venous blood dosing model best characterized vatiquinone lymphatic absorption.

    Article Title: A review of physiologically based pharmacokinetic modeling of renal drug disposition.
    Article Snippet: Recently, an Innovation and Quality Consortium effort (Heimbach et al, 2021) has also been conducted to summarize the industrial experience in applying PBPKmodeling (Simcyp V15) in RI where the AUC ratios of RI to healthy control were predicted within 2-fold of the observed ratios for >90% of all cases.

    Drug discovery:

    Article Title: A tutorial on physiologically based pharmacokinetic approaches in lactation research
    Article Snippet: .. A verified PBPK model in Simcyp simulator version 21 for efavirenz describing the CYP3A4‐ and CYP2B6‐mediated auto‐induction during multiple dosing was able to accurately predict efavirenz pharmacokinetics in African mothers at post‐partum with different CYP2B6 genotypes (516GG, GT, and TT). ..

    Software:

    Article Title: Mathematical Albumin Function for Neonates Undergoing Therapeutic Hypothermia in Comparison with Control Neonates
    Article Snippet: .. The developed HSA function of this study was compared to the existing HSA function in the available PBPK modeling software Simcyp (Simcyp simulator version 22, release 1, Sheffield, UK): HSA = 33.746 + 1.1287*log(PNA) (Simcyp function). .. This Simcyp function represents the general neonatal population, not specifically HIE cases.

    In Vitro:

    Article Title: 2024 Annual Meeting American College of Clinical Pharmacology®.
    Article Snippet: .. A combination of in vitro data and clinical PK data following single and multiple dosing of 70 mg QD lirafugratinib in cancer patients were used to develop the PBPK model using Simcyp® v21 simulator. .. Pharmacokinetics (PK) obtained from the lirafugratinib/itraconazole clinical DDI study and patient study (additional doses of 20 – 100mg QD or BID) were used to verify the PBPK model.



    Similar Products

    simcyp® v21  (Simcyp)
    90
    Simcyp simcyp® v21
    Simcyp® V21, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/simcyp+v19/pm39934586-93-16-16
    Average 90 stars, based on 1 article reviews
    simcyp® v21 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    simcyp v21  (Certara L.P)
    90
    Certara L.P simcyp v21
    Simcyp V21, supplied by Certara L.P, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/simcyp+v21/med_rxiv__2024__12__17__24319139-27-5-7
    Average 90 stars, based on 1 article reviews
    simcyp v21 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    simcyp v21  (Simcyp)
    90
    Simcyp simcyp v21
    Simcyp V21, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/simcyp+v19/pm39656410-3-24-25
    Average 90 stars, based on 1 article reviews
    simcyp v21 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    dynamic simulations simcyp v21  (Simcyp)
    90
    Simcyp dynamic simulations simcyp v21
    Dynamic Simulations Simcyp V21, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/simcyp+v19/pmc11762507-60-25-26
    Average 90 stars, based on 1 article reviews
    dynamic simulations simcyp v21 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    simcyp pbpk simulator v21  (Certara L.P)
    90
    Certara L.P simcyp pbpk simulator v21
    Key <t>PBPK</t> modelling steps and components of each clinical study used in model development, refinement, verification and application. BCRP, breast cancer resistance protein; DDI, drug–drug interaction; fu inc , fraction of unbound dersimelagon in in vitro system; K m , Michaelis constant; MAD, multiple ascending dose; OATP, organic anion transporting polypeptide; PBPK, physiologically based pharmacokinetic; PK, pharmacokinetic; QD, once daily; V max , maximum velocity of reaction; V ss , volume of distribution at steady state.
    Simcyp Pbpk Simulator V21, supplied by Certara L.P, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/simcyp+simulator+v23/pmc11773107-133-6-10
    Average 90 stars, based on 1 article reviews
    simcyp pbpk simulator v21 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    simcyp simulator v21  (Simcyp)
    90
    Simcyp simcyp simulator v21
    Key <t>PBPK</t> modelling steps and components of each clinical study used in model development, refinement, verification and application. BCRP, breast cancer resistance protein; DDI, drug–drug interaction; fu inc , fraction of unbound dersimelagon in in vitro system; K m , Michaelis constant; MAD, multiple ascending dose; OATP, organic anion transporting polypeptide; PBPK, physiologically based pharmacokinetic; PK, pharmacokinetic; QD, once daily; V max , maximum velocity of reaction; V ss , volume of distribution at steady state.
    Simcyp Simulator V21, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/simcyp+v19/pm39218776-573-17-17
    Average 90 stars, based on 1 article reviews
    simcyp simulator v21 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    pbpk model using simcyp® v21 simulator  (Simcyp)
    90
    Simcyp pbpk model using simcyp® v21 simulator
    Key <t>PBPK</t> modelling steps and components of each clinical study used in model development, refinement, verification and application. BCRP, breast cancer resistance protein; DDI, drug–drug interaction; fu inc , fraction of unbound dersimelagon in in vitro system; K m , Michaelis constant; MAD, multiple ascending dose; OATP, organic anion transporting polypeptide; PBPK, physiologically based pharmacokinetic; PK, pharmacokinetic; QD, once daily; V max , maximum velocity of reaction; V ss , volume of distribution at steady state.
    Pbpk Model Using Simcyp® V21 Simulator, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/13+compartment+full+pbpk+model+simcyp++population+based+simulator+version+12+1/pm39218776-551-31-31
    Average 90 stars, based on 1 article reviews
    pbpk model using simcyp® v21 simulator - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    simcyp™ pbpk simulator v21 release 1  (Certara L.P)
    90
    Certara L.P simcyp™ pbpk simulator v21 release 1
    Key <t>PBPK</t> modelling steps and components of each clinical study used in model development, refinement, verification and application. BCRP, breast cancer resistance protein; DDI, drug–drug interaction; fu inc , fraction of unbound dersimelagon in in vitro system; K m , Michaelis constant; MAD, multiple ascending dose; OATP, organic anion transporting polypeptide; PBPK, physiologically based pharmacokinetic; PK, pharmacokinetic; QD, once daily; V max , maximum velocity of reaction; V ss , volume of distribution at steady state.
    Simcyp™ Pbpk Simulator V21 Release 1, supplied by Certara L.P, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/simcyp+simulator+v23/pm38923321-40-3-8
    Average 90 stars, based on 1 article reviews
    simcyp™ pbpk simulator v21 release 1 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    simcyp v21 simulator  (Simcyp)
    90
    Simcyp simcyp v21 simulator
    Key <t>PBPK</t> modelling steps and components of each clinical study used in model development, refinement, verification and application. BCRP, breast cancer resistance protein; DDI, drug–drug interaction; fu inc , fraction of unbound dersimelagon in in vitro system; K m , Michaelis constant; MAD, multiple ascending dose; OATP, organic anion transporting polypeptide; PBPK, physiologically based pharmacokinetic; PK, pharmacokinetic; QD, once daily; V max , maximum velocity of reaction; V ss , volume of distribution at steady state.
    Simcyp V21 Simulator, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/simcyp+v19/pmc11533107__PSP4___13___1528___s001-21-19-19
    Average 90 stars, based on 1 article reviews
    simcyp v21 simulator - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    caffeine, s-warfarin, omeprazole, midazolam, simvastatin and cyclosporin compound files from simcyp v21  (Simcyp)
    90
    Simcyp caffeine, s-warfarin, omeprazole, midazolam, simvastatin and cyclosporin compound files from simcyp v21
    Key <t>PBPK</t> modelling steps and components of each clinical study used in model development, refinement, verification and application. BCRP, breast cancer resistance protein; DDI, drug–drug interaction; fu inc , fraction of unbound dersimelagon in in vitro system; K m , Michaelis constant; MAD, multiple ascending dose; OATP, organic anion transporting polypeptide; PBPK, physiologically based pharmacokinetic; PK, pharmacokinetic; QD, once daily; V max , maximum velocity of reaction; V ss , volume of distribution at steady state.
    Caffeine, S Warfarin, Omeprazole, Midazolam, Simvastatin And Cyclosporin Compound Files From Simcyp V21, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/simcyp+v21/caffeine++s+warfarin++omeprazole++midazolam++simvastatin+and+cyclosporin+compound+files+from+simcyp+v21/pmc11247108-78-12-21
    Average 90 stars, based on 1 article reviews
    caffeine, s-warfarin, omeprazole, midazolam, simvastatin and cyclosporin compound files from simcyp v21 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Key PBPK modelling steps and components of each clinical study used in model development, refinement, verification and application. BCRP, breast cancer resistance protein; DDI, drug–drug interaction; fu inc , fraction of unbound dersimelagon in in vitro system; K m , Michaelis constant; MAD, multiple ascending dose; OATP, organic anion transporting polypeptide; PBPK, physiologically based pharmacokinetic; PK, pharmacokinetic; QD, once daily; V max , maximum velocity of reaction; V ss , volume of distribution at steady state.

    Journal: British Journal of Clinical Pharmacology

    Article Title: Physiologically based pharmacokinetic modelling to predict potential drug–drug interactions of dersimelagon (MT‐7117)

    doi: 10.1111/bcp.16271

    Figure Lengend Snippet: Key PBPK modelling steps and components of each clinical study used in model development, refinement, verification and application. BCRP, breast cancer resistance protein; DDI, drug–drug interaction; fu inc , fraction of unbound dersimelagon in in vitro system; K m , Michaelis constant; MAD, multiple ascending dose; OATP, organic anion transporting polypeptide; PBPK, physiologically based pharmacokinetic; PK, pharmacokinetic; QD, once daily; V max , maximum velocity of reaction; V ss , volume of distribution at steady state.

    Article Snippet: All simulations were conducted using the Simcyp PBPK Simulator v21 (Certara), which integrates demographic, physiological, genomic and in vitro biochemical data to allow prediction of PK in virtual healthy populations.

    Techniques: In Vitro

    Input parameters of the physiologically based pharmacokinetic model for dersimelagon.

    Journal: British Journal of Clinical Pharmacology

    Article Title: Physiologically based pharmacokinetic modelling to predict potential drug–drug interactions of dersimelagon (MT‐7117)

    doi: 10.1111/bcp.16271

    Figure Lengend Snippet: Input parameters of the physiologically based pharmacokinetic model for dersimelagon.

    Article Snippet: All simulations were conducted using the Simcyp PBPK Simulator v21 (Certara), which integrates demographic, physiological, genomic and in vitro biochemical data to allow prediction of PK in virtual healthy populations.

    Techniques: Binding Assay, Software, Permeability, In Vitro, Inhibition